Bullfrog AI Holdings (Bullfrog AI Holdings) Cash, Cash Equivalents, Marketable Securities : $7.01 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Bullfrog AI Holdings Cash, Cash Equivalents, Marketable Securities?

Bullfrog AI Holdings's quarterly cash, cash equivalents, marketable securities declined from Sep. 2023 ($3.86 Mil) to Dec. 2023 ($2.63 Mil) but then increased from Dec. 2023 ($2.63 Mil) to Mar. 2024 ($7.01 Mil).

Bullfrog AI Holdings's annual cash, cash equivalents, marketable securities increased from Dec. 2021 ($0.01 Mil) to Dec. 2022 ($0.06 Mil) and increased from Dec. 2022 ($0.06 Mil) to Dec. 2023 ($2.63 Mil).

Bullfrog AI Holdings Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Bullfrog AI Holdings's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bullfrog AI Holdings Cash, Cash Equivalents, Marketable Securities Chart

Bullfrog AI Holdings Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Cash, Cash Equivalents, Marketable Securities

0.01

0.06

2.63

Bullfrog AI Holdings Quarterly Data
	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash, Cash Equivalents, Marketable Securities	Get a 7-Day Free Trial								5.42	5.46	3.86	2.63	7.01

Bullfrog AI Holdings Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Bullfrog AI Holdings (NAS:BFRG) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Bullfrog AI Holdings Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Bullfrog AI Holdings's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Bullfrog AI Holdings (Bullfrog AI Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bullfrog AI Holdings Inc (NAS:BFRG) » Definitions » Cash, Cash Equivalents, Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

325 Ellington Boulevard, Unit 317, Gaithersburg, MD, USA, 20878

Website

https://www.bullfrogai.com

Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.

Executives

William Enright	director	910 CLOPPER ROAD, SUITE 201S, GAITHERSBURG MD 20878
R Don Elsey	director	2273 RESEARCH BLVD, SUITE 400, ROCKVILLE MD 20850
Dane R Saglio	officer: Chief Financial Officer
Jason David Hanson	director	8125 NORTH HAYDEN ROAD, SCOTTSDALE AZ 85258-2463
Vininder Singh	director, 10 percent owner, officer: Chief Executive Officer	4 BLACK KETTLE COURT, BOYDS MD 20841